CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 1 filers reported holding CUREVAC N V in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $666 | -45.4% | 97,646 | -16.5% | 0.00% | -100.0% |
| Q2 2023 | $1,219 | +74.6% | 116,942 | +16.8% | 0.00% | – |
| Q1 2023 | $698 | -7.5% | 100,160 | -20.0% | 0.00% | – |
| Q4 2022 | $755 | -99.9% | 125,250 | +76.3% | 0.00% | -100.0% |
| Q3 2022 | $561,000 | -81.3% | 71,055 | -67.7% | 0.00% | -50.0% |
| Q2 2022 | $2,994,000 | +86.4% | 220,006 | +168.8% | 0.00% | +100.0% |
| Q1 2022 | $1,606,000 | – | 81,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $171,200,000 | 50.12% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 61,100 | $3,337,000 | 0.35% |
| Renaissance Capital LLC | 25,454 | $1,390,000 | 0.28% |
| Green Alpha Advisors, LLC | 5,170 | $282,000 | 0.20% |
| Caption Management, LLC | 304,400 | $16,626,000 | 0.19% |
| Paradigm Financial Advisors, LLC | 14,009 | $765,000 | 0.18% |
| Baillie Gifford | 3,940,731 | $215,243,000 | 0.11% |
| MANGROVE PARTNERS IM, LLC | 20,200 | $1,103,000 | 0.10% |
| MANGROVE PARTNERS IM, LLC | 20,200 | $1,103,000 | 0.10% |
| Ergoteles LLC | 43,358 | $2,368,000 | 0.09% |